Skip to content

Effects of Temporary Inhibition of the Renin-Angiotensin System on future blood pressure and hypertensive organ damage in young prehypertensive adults - TIResiAS.

Effects of Temporary Inhibition of the Renin-Angiotensin System on future blood pressure and hypertensive organ damage in young prehypertensive adults - TIResiAS.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22745
Enrollment
300
Registered
2006-09-20
Start date
2007-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prehypertension, defined as an avarage office blood pressure of 130-139/85-89 mmHg.

Interventions

Individuals are randomized to receive either lisinopril 10mg daily for three weeks followed by a forced titration to lisinopril 20mg daily or matched placebo for a period of one year. This is followed

Sponsors

Academic Medical Centre Dept.Vascular Medicine Meibergdreef 9 1105 AZ Amsterdam The Netherlands Tel +31 20 5669111
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Otherwise healthy persons aged 18-40 years with 3 cardiovascular risk factors or less and an average blood pressure of 130-139 systolic/below 90 mmHg diastolic and/or below 130 systolic/ 85-89 mmHg diastolic on 2 separate visits with an interval of 1 week and measured by a validated automatic blood pressure device.

Exclusion criteria

Exclusion criteria: 1. Previous antihypertensive treatment; 2. Any chronic use of prescribed oral medication except oral contraceptives; 3. An elevated baseline serum glucose (>7.0 mmol/L) or elevated serum creatinine(> 95 ummol/L for women and >110 ummol/L for men); 4. Women with a wish to become pregnant in the treatment period.

Design outcomes

Primary

MeasureTime frame
Differences in ambulatory blood pressure between lisinopril and placebo 2 years after cessation of active treatment compared to baseline.

Secondary

MeasureTime frame
Differences in left ventricular mass (index) and microalbuminuria between lisinopril and placebo 2 years after cessation of active treatment compared to baseline.

Contacts

Public ContactB. Bogaard, van den

Academic Medical Center Department of Vascular Medicine (room F4-255) P.O. Box 22660

B.vandenBogaard@amc.uva.nl /b.vandenbogaard@amc.nl+31 (0)20 5668675

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)